FDA Approved: FULVESTRANT — Original Application (Sandoz Inc)

View source ↗

Summary

The FDA approved Sandoz's original ANDA for fulvestrant, providing a generic version of the breast cancer therapy Fulvestrant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (generic) (Fulvestrant)

Snippet

ORIG AP for FULVESTRANT (FULVESTRANT)